Biotech · Private company · Hockessin, DE, US
Vishenary, LLC
Track this companyFree. Adds Vishenary, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- A novel Th17-enhancing adjuvant and conserved antigen for protection against viral/bacterial co-infectionFiscal year 2026 · $283KNIH RePORTER 5R41AI188733-02 · fetched Nov 12, 2026
- A novel Th17-enhancing adjuvant and conserved antigen for protection against viral/bacterial co-infectionFiscal year 2025 · $308.7KNIH RePORTER 1R41AI188733-01A1 · fetched Nov 12, 2026